Clal Biotechnology Stock Forecast - Triple Exponential Smoothing

CBI Stock   44.60  3.50  8.52%   
The Triple Exponential Smoothing forecasted value of Clal Biotechnology Industries on the next trading day is expected to be 44.48 with a mean absolute deviation of  0.94  and the sum of the absolute errors of 55.55. Clal Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Clal Biotechnology stock prices and determine the direction of Clal Biotechnology Industries's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Clal Biotechnology's historical fundamentals, such as revenue growth or operating cash flow patterns.
Check out Historical Fundamental Analysis of Clal Biotechnology to cross-verify your projections.
  
Most investors in Clal Biotechnology cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Clal Biotechnology's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Clal Biotechnology's price structures and extracts relationships that further increase the generated results' accuracy.
Triple exponential smoothing for Clal Biotechnology - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When Clal Biotechnology prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in Clal Biotechnology price movement. However, neither of these exponential smoothing models address any seasonality of Clal Biotechnology.

Clal Biotechnology Triple Exponential Smoothing Price Forecast For the 18th of April 2024

Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Clal Biotechnology Industries on the next trading day is expected to be 44.48 with a mean absolute deviation of 0.94, mean absolute percentage error of 1.53, and the sum of the absolute errors of 55.55.
Please note that although there have been many attempts to predict Clal Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Clal Biotechnology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Clal Biotechnology Stock Forecast Pattern

Backtest Clal BiotechnologyClal Biotechnology Price PredictionBuy or Sell Advice 

Clal Biotechnology Forecasted Value

In the context of forecasting Clal Biotechnology's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Clal Biotechnology's downside and upside margins for the forecasting period are 41.59 and 47.36, respectively. We have considered Clal Biotechnology's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
44.60
44.48
Expected Value
47.36
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Clal Biotechnology stock data series using in forecasting. Note that when a statistical model is used to represent Clal Biotechnology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors 0.1362
MADMean absolute deviation0.9415
MAPEMean absolute percentage error0.0225
SAESum of the absolute errors55.546
As with simple exponential smoothing, in triple exponential smoothing models past Clal Biotechnology observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older Clal Biotechnology Industries observations.

Predictive Modules for Clal Biotechnology

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Clal Biotechnology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Clal Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
41.7244.6047.48
Details
Intrinsic
Valuation
LowRealHigh
33.4336.3149.06
Details
Bollinger
Band Projection (param)
LowMiddleHigh
40.5343.5746.61
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Clal Biotechnology. Your research has to be compared to or analyzed against Clal Biotechnology's peers to derive any actionable benefits. When done correctly, Clal Biotechnology's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Clal Biotechnology.

Other Forecasting Options for Clal Biotechnology

For every potential investor in Clal, whether a beginner or expert, Clal Biotechnology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Clal Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Clal. Basic forecasting techniques help filter out the noise by identifying Clal Biotechnology's price trends.

Clal Biotechnology Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Clal Biotechnology stock to make a market-neutral strategy. Peer analysis of Clal Biotechnology could also be used in its relative valuation, which is a method of valuing Clal Biotechnology by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Clal Biotechnology Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Clal Biotechnology's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Clal Biotechnology's current price.

Clal Biotechnology Market Strength Events

Market strength indicators help investors to evaluate how Clal Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Clal Biotechnology shares will generate the highest return on investment. By undertsting and applying Clal Biotechnology stock market strength indicators, traders can identify Clal Biotechnology Industries entry and exit signals to maximize returns.

Clal Biotechnology Risk Indicators

The analysis of Clal Biotechnology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Clal Biotechnology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting clal stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Clal Biotechnology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Clal Biotechnology's short interest history, or implied volatility extrapolated from Clal Biotechnology options trading.

Pair Trading with Clal Biotechnology

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Clal Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clal Biotechnology will appreciate offsetting losses from the drop in the long position's value.

Moving together with Clal Stock

  0.77GPGB GP Global PowerPairCorr

Moving against Clal Stock

  0.45BOLT BioLight Life SciencesPairCorr
The ability to find closely correlated positions to Clal Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clal Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clal Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Clal Biotechnology Industries to buy it.
The correlation of Clal Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Clal Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Clal Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Clal Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Historical Fundamental Analysis of Clal Biotechnology to cross-verify your projections.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Clal Stock analysis

When running Clal Biotechnology's price analysis, check to measure Clal Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clal Biotechnology is operating at the current time. Most of Clal Biotechnology's value examination focuses on studying past and present price action to predict the probability of Clal Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clal Biotechnology's price. Additionally, you may evaluate how the addition of Clal Biotechnology to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Please note, there is a significant difference between Clal Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clal Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clal Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.